Atlas Trials

Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-

Clinical trial NCT00392197 · COMPLETED

Trial details

NCT number
NCT00392197
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2006-11-01
Primary completion
2010-03-01
Enrollment
111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.